-
1
-
-
0002199444
-
Cytokeratin 5/6 is an effective substitute for Keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies
-
Abrahams NA, Ormsby AO, Brainard J. Cytokeratin 5/6 is an effective substitute for Keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies [Abstract]. Mod Pathol 2001;14:100.
-
(2001)
Mod Pathol
, vol.14
, pp. 100
-
-
Abrahams, N.A.1
Ormsby, A.O.2
Brainard, J.3
-
2
-
-
0028344274
-
Analysis of cribriform morphology in prostatic neoplasia using antibody to high-molecular weight cytokeratins
-
Amin MB, Schultz DS, Zarbo RJ. Analysis of cribriform morphology in prostatic neoplasia using antibody to high-molecular weight cytokeratins. Arch Pathol Lab Med 1994;118:260-4.
-
(1994)
Arch Pathol Lab Med
, vol.118
, pp. 260-264
-
-
Amin, M.B.1
Schultz, D.S.2
Zarbo, R.J.3
-
3
-
-
0033991986
-
A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy
-
Babaian RJ, Toi A, Kamoi K, et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000;163:152-7.
-
(2000)
J Urol
, vol.163
, pp. 152-157
-
-
Babaian, R.J.1
Toi, A.2
Kamoi, K.3
-
4
-
-
0035050193
-
Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer
-
Gore JL, Shariat SF, Miles BJ, et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 2001;165:1554-9.
-
(2001)
J Urol
, vol.165
, pp. 1554-1559
-
-
Gore, J.L.1
Shariat, S.F.2
Miles, B.J.3
-
5
-
-
0036157392
-
Cancer statistics, 2002
-
Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
-
(2002)
CA Cancer J Clin
, vol.52
, pp. 23-47
-
-
Jemal, A.1
Thomas, A.2
Murray, T.3
-
6
-
-
0034765524
-
P504S: A new molecular marker for the detection of prostate carcinoma
-
Jiang Z, Woda BA, Rock KL, et al. P504S: A new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 2001;25:1397-404.
-
(2001)
Am J Surg Pathol
, vol.25
, pp. 1397-1404
-
-
Jiang, Z.1
Woda, B.A.2
Rock, K.L.3
-
7
-
-
0011770533
-
Expression of P504S in variant malignant neoplasms and normal tissues, a study of 715 cases
-
Jiang Z, Woda BA, Dresser K, et al. Expression of P504S in variant malignant neoplasms and normal tissues, a study of 715 cases [Abstract]. Mod Pathol 2002;15:306.
-
(2002)
Mod Pathol
, vol.15
, pp. 306
-
-
Jiang, Z.1
Woda, B.A.2
Dresser, K.3
-
8
-
-
0011742189
-
High molecular weight cytokeratin reactivity in prostate carcinoma
-
Oliai BR, Kahane H, Epstein JI. High molecular weight cytokeratin reactivity in prostate carcinoma [Abstract]. Mod Pathol 2002;15:176.
-
(2002)
Mod Pathol
, vol.15
, pp. 176
-
-
Oliai, B.R.1
Kahane, H.2
Epstein, J.I.3
-
9
-
-
0037012476
-
α-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer
-
Rubin MA, Zhou M, Dhanasekaran SM, et al. α-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002;287:1662-70.
-
(2002)
JAMA
, vol.287
, pp. 1662-1670
-
-
Rubin, M.A.1
Zhou, M.2
Dhanasekaran, S.M.3
-
10
-
-
0011777232
-
Comparison of the basal cell-specific markers, p63 and 34βE12, in the diagnosis of prostate cancer
-
Shah R, Zhou M, LeBlanc M, et al. Comparison of the basal cell-specific markers, p63 and 34βE12, in the diagnosis of prostate cancer [Abstract]. Mod Pathol 2002;15:181.
-
(2002)
Mod Pathol
, vol.15
, pp. 181
-
-
Shah, R.1
Zhou, M.2
LeBlanc, M.3
-
11
-
-
0036249705
-
Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsies: A study of 250 consecutive cases in a routine surgical pathology practice
-
Varma M, Lee MW, Tamboli P, et al. Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsies: A study of 250 consecutive cases in a routine surgical pathology practice. Arch Pathol Lab Med 2002;126:554-61.
-
(2002)
Arch Pathol Lab Med
, vol.126
, pp. 554-561
-
-
Varma, M.1
Lee, M.W.2
Tamboli, P.3
-
12
-
-
0034654176
-
Identification of differentially expressed genes in human prostate cancer using subtraction and microarray
-
Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 2000;60:1677-82.
-
(2000)
Cancer Res
, vol.60
, pp. 1677-1682
-
-
Xu, J.1
Stolk, J.A.2
Zhang, X.3
-
13
-
-
0011747561
-
P504S in diagnosis of prostate cancer: A multi-institutional analysis
-
Yang XJ, Wu CL, Amin MB, et al. P504S in diagnosis of prostate cancer: A multi-institutional analysis [Abstract]. Mod Pathol 2002;15:187.
-
(2002)
Mod Pathol
, vol.15
, pp. 187
-
-
Yang, X.J.1
Wu, C.L.2
Amin, M.B.3
-
14
-
-
0011747561
-
Expression of P504S in atypical adenomatous hyperplasia of the prostate
-
Yang XJ, Wu CL, Tretiakova M, et al. Expression of P504S in atypical adenomatous hyperplasia of the prostate [Abstract]. Mod Pathol 2002;15:187.
-
(2002)
Mod Pathol
, vol.15
, pp. 187
-
-
Yang, X.J.1
Wu, C.L.2
Tretiakova, M.3
-
15
-
-
0003608841
-
-
3rd series, fascicle 28. Washington, DC: Armed Forces Institute of Pathology
-
Young RH, Srigley JR, Amin MB, et al. Atlas of Tumor Pathology: Tumors of the Prostate Gland, Seminal Vesicles, Male Urethra, and Penis, 3rd series, fascicle 28. Washington, DC: Armed Forces Institute of Pathology, 2000.
-
(2000)
Atlas of Tumor Pathology: Tumors of the Prostate Gland, Seminal Vesicles, Male Urethra, and Penis
-
-
Young, R.H.1
Srigley, J.R.2
Amin, M.B.3
|